Live Breaking News & Updates on European urology

Stay informed with the latest breaking news from European urology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in European urology and stay connected to the pulse of your community

ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , United-kingdom , Texas , United-states , American , British , Andrea-maddox-smith , Jonathan-suderman , Ashish-kamat , Peter-black

European Urology Names Fox Chase Cancer Center's Dr. Andres F. Correa Reviewer of the Month

The journal European Urology has named Fox Chase Cancer Center urologic oncologist Andres F. Correa, MD, its March 2024 Reviewer of the Month.

United-states , Philadelphia , Pennsylvania , Fox-chase-cancer-center , Spain , Fox-chase , American , Spanish , Andresf-correa , Alexander-kutikov , University-of-maryland-school-medicine , American-urological-association

Prostate cancer screening must be done every 5 years: Study

A simple blood test that checks for prostate-specific antigen (PSA), a marker for prostate cancer, is safe and sufficient, if done at intervals of every five years, finds a study on Saturday.

France , New-delhi , Delhi , India , Germany , Paris , France-general- , Peter-albers , Heinrich-heine-university , Lancet-commission-on , European-association-of-urology , Department-of-urology

Prostate cancer screening must be done every 5-years: Study

Prostate cancer screening has long been contentious. While the PSA test is useful for assessing risk, it's notorious for false positives prompting unnecessary invasive treatments and false negatives resulting in undetected cancers

France , Paris , France-general- , Germany , New-delhi , Delhi , India , Peter-albers , Department-of-urology , European-association-of-urology , Lancet-commission-on , Heinrich-heine-university

Prostate Cancer Screening Must Be Done Every 5-Years: Study

Prostate Cancer Screening Must Be Done Every 5-Years: Study
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

France , New-delhi , Delhi , India , Paris , France-general- , Germany , Peter-albers , European-association-of-urology , Lancet-commission-on , Department-of-urology , Heinrich-heine-university

Prostate cancer screening must be done every 5 years: Study

Prostate cancer screening must be done every 5 years: Study Screening for prostate cancer has historically been a controversial subject

France , Germany , Paris , France-general- , Peter-albers , Department-of-urology , European-association-of-urology , Lancet-commission-on , Heinrich-heine-university , European-association , Lancet-commission , European-urology

Prostate Cancer Screening Must Be Done Every 5-years: Study

A simple blood test that checks for prostate-specific antigen (PSA), a marker for prostate cancer,

France , Paris , France-general- , New-delhi , Delhi , India , Germany , Peter-albers , European-association-of-urology , Lancet-commission-on , Department-of-urology , Heinrich-heine-university

Prostate Cancer Screening Every 5 Years Can Save Lives

Men with prostate specific antigen (PSA) levels between 1.5-3 ng/ml were deemed intermediate risk for prostate cancer and reevaluated in two years.

France , Paris , France-general- , Germany , Peter-albers , Lancet-commission , Heinrich-heine-university , European-association-of-urology , Department-of-urology , Prostate-cancer-screening , European-association , European-urology

Neoadjuvant Pembrolizumab for MIBC Improves Outcomes - Renal and Urology News

Neoadjuvant pembrolizumab appeared to offer more favorable results among both cisplatin-eligible and cisplatin-ineligible patients. A study compared response to neoadjuvant pembrolizumab vs chemo prior to surgery for muscle-invasive bladder cancer (MIBC).

Florida , United-states , Tampa , Italy , Roger-li , Moffitt-cancer-center , European-urology ,

Post-RARP Outcomes Worse for Prostate Cancer of Unconventional Histology

Erectile dysfunction was twice as likely among men with prostate cancer of unconventional vs typical histology undergoing surgery. Investigators studied the prognostic value of prostate cancer unconventional histology on oncologic and functional outcomes after surgery.

Jeremy-yuen-chun-teoh , Chinese-university-of-hong-kong , Yuen-chun-teoh , Chinese-university , Hong-kong , European-urology ,